- Corporate Officers - L
- Ladone Mary Kay
Insider Trading History of Ladone Mary Kay
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ladone Mary Kay since 2019.
This trader's CIK number is 1760737.
At the time of last reporting, Ladone Mary Kay was the Director of Novanta Inc. (stock ticker symbol NOVT).
Also see all insider trading activities at Novanta Inc.
Note that in the past
Ladone Mary Kay also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Novanta Inc (NOVT) by Ladone Mary Kay
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | NOVT | 0 | $0 | 0 | $0 | 572 | $0 |
Yearly summary of insider trading at Hill-rom Holdings, Inc. (HRC) by Ladone Mary Kay
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | HRC | 0 | $0 | 22,346 | $2,922,890 | 13,947 | $899,435 |
| 2020 | HRC | 0 | $0 | 5,403 | $581,830 | 9,821 | $803,355 |
| 2019 | HRC | 0 | $0 | 0 | $0 | 10,008 | $869,504 |
Yearly summary of insider trading at Bioventus Inc. (BVS) by Ladone Mary Kay
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | BVS | 0 | $0 | 0 | $0 | 26,493 | $0 |
| 2024 | BVS | 0 | $0 | 0 | $0 | 32,214 | $0 |
| 2023 | BVS | 0 | $0 | 0 | $0 | 18,461 | $0 |
| 2022 | BVS | 0 | $0 | 0 | $0 | 1,813 | $0 |
Insider trading activities at 3 companies by Ladone Mary Kay:
1. Novanta Inc (NOVT)
2. Hill-rom Holdings, Inc. (HRC)
3. Bioventus Inc. (BVS)
Table 1. Insider trading of Novanta Inc (NOVT) by Ladone Mary Kay
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-07-11 | NOVT | Option Ex | 572 | .00 | 0 |
Table 2. Insider trading of Hill-rom Holdings, Inc. (HRC) by Ladone Mary Kay
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-12 | HRC | Option Ex | 700 | .00 | 0 |
| 2021-11-11 | HRC | Option Ex | 2,018 | 94.14 | 189,974 |
| 2021-11-11 | HRC | Sale | 2,018 | 155.14 | 313,072 |
| 2021-11-08 | HRC | Option Ex | 5,522 | 45.32 | 250,240 |
| 2021-11-08 | HRC | Sale | 2,923 | 155.08 | 453,298 |
| 2021-07-28 | HRC | Option Ex | 3,358 | 90.64 | 304,352 |
| 2021-07-28 | HRC | Sale | 9,056 | 127.50 | 1,154,640 |
| 2021-07-23 | HRC | Sale | 8,349 | 120.00 | 1,001,880 |
| 2021-07-23 | HRC | Option Ex | 2,349 | 65.93 | 154,869 |
| 2020-11-09 | HRC | Option Ex | 3,586 | 95.75 | 343,359 |
| 2020-11-03 | HRC | Option Ex | 1,418 | 91.54 | 129,803 |
| 2020-06-30 | HRC | Sale | 2,278 | 110.00 | 250,580 |
| 2020-06-26 | HRC | Sale | 3,125 | 106.00 | 331,250 |
| 2020-06-26 | HRC | Option Ex | 3,125 | 53.70 | 167,812 |
| 2020-03-06 | HRC | Option Ex | 1,692 | 95.97 | 162,381 |
| 2019-11-15 | HRC | Option Ex | 1,185 | 104.43 | 123,749 |
| 2019-11-08 | HRC | Option Ex | 1,960 | 103.73 | 203,310 |
| 2019-11-05 | HRC | Option Ex | 3,539 | 103.72 | 367,065 |
| 2019-07-22 | HRC | Option Ex | 1,647 | .00 | 0 |
| 2019-03-06 | HRC | Option Ex | 1,677 | 104.58 | 175,380 |
Table 3. Insider trading of Bioventus Inc. (BVS) by Ladone Mary Kay
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-06-02 | BVS | Option Ex | 26,493 | .00 | 0 |
| 2024-06-16 | BVS | Option Ex | 1,814 | .00 | 0 |
| 2024-06-07 | BVS | Option Ex | 30,400 | .00 | 0 |
| 2023-06-16 | BVS | Option Ex | 1,813 | .00 | 0 |
| 2023-06-06 | BVS | Option Ex | 16,648 | .00 | 0 |
| 2022-06-16 | BVS | Option Ex | 1,813 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ladone Mary Kay
(Director of Novanta Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.